Showing results (351-360 of 521) with videos related to
Sort By:
Pageof 53
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|December 7, 2018
Separate and interacting effects of the endogenous circadian system and behaviors on plasma aldosterone in humansSaurabh S Thosar, Jose F Rueda, Alec M Berman, et al.Circulation|April 28, 2017
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart AssociationSheryl L Chow, Alan S Maisel, Inder Anand, et al.European Heart Journal|May 2, 2017
Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF)Peter S Pang, Javed Butler, Sean P Collins, et al.International Journal of Cardiology|January 8, 2018
Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHFMarco Metra, Beth A Davison, Claudio Gimpelewicz, et al.JACC. Heart Failure|April 28, 2023
Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT TrialMuhammad Shahzeb Khan, Sumitabh Singh, Matthew W Segar, et al.JACC. Heart Failure|February 5, 2015
Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure)G Michael Felker, Javed Butler, Sean P Collins, et al.JACC. Heart Failure|December 3, 2014
Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injuryTariq Ahmad, Teresa Wang, Emily C O'Brien, et al.Circulation. Heart Failure|March 3, 2022
Developments in Exercise Capacity Assessment in Heart Failure Clinical Trials and the Rationale for the Design of METEORIC-HFGregory D Lewis, Kieran F Docherty, Adriaan A Voors, et al.European Journal of Heart Failure|July 4, 2023
Changes in mid-regional pro-adrenomedullin during treatment with sacubitril/valsartanPeder L Myhre, Yuxi Liu, Ian J Kulac, et al.Journal of the American Heart Association|December 11, 2019
Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines-Heart FailureJacob P Kelly, Adam D DeVore, JingJing Wu, et al.Pageof 53